Ocugen engagement report
@Ocugen - 65K followers on X
Measured over 11 original posts from a 30-day window, last computed on September 24, 2026.
Engagement
A typical post picks up 117 interactions against 65K followers, an engagement rate of 0.182%. Measured over 11 original posts, its engagement rate beats 58% of 21,185 tracked accounts of a similar size, which puts it in the middle of its size range rather than at either end. Posts are seen about 5.5K times each, and 2.14% of those impressions turn into an interaction. That is about 8.49% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 0.4 posts a day over the last 30 days, though only 40% of days saw any activity at all. Most posts go out around 13:00 UTC, and Tuesday is the busiest day of the week. Of the 11 posts sampled, 91% carry an image or video and 45% link out. The account's strongest tracked post pulled 189 interactions, about 1.6x its own typical post. Recurring topics include #ocu410, #biotech, #genetherapy.
Measured over 11 original posts from a 30-day window, last computed on September 24, 2026. Recurring tags: #ocu410, #biotech, #genetherapy.
Compared with accounts its own size
Ocugen's engagement rate beats 58% of the tracked X accounts closest to it in follower count (21,185 accounts, accounts of similar size (decile 6 of 10)). A percentile is spread evenly by construction, so 50 really is the middle of that group and 90 really is its top tenth.
On engagement per impression rather than per follower it beats 61% of the same group. When those two numbers disagree, the gap is about how far its posts travel rather than how people react to them.
Where this sits in the catalog
At 0.182%, Ocugen sits above the 50th percentile of the 213,098 accounts in this comparison. That places it in the above the median band, which runs 0.147% to 0.698%.
Show the percentile table
| Percentile | Engagement rate |
|---|---|
| 10th percentile | 0.004% |
| 25th percentile | 0.025% |
| 50th percentile | 0.147% |
| 75th percentile | 0.698% |
| 90th percentile | 2.61% |
| 99th percentile | 82.9% |
This ruler is the whole measured catalog, not a size-matched group: it shows where the raw rate falls across every account we can measure, all of which are large. For a like-for-like comparison, read the size-band percentile above instead. See how the bands are built
Posting timing
This account posts most often around 13:00 UTC, and Tuesday is its busiest day of the week. The bars below are the catalog-wide pattern, with this account's own busiest slot marked. They do not show how this account performs at each hour: we keep one aggregate per account, not one per hour, so that measurement does not exist in our data.
Show engagement by hour posted, utc as a table
| Hour (UTC) | Vs author median | Posts |
|---|---|---|
| 00:00 UTC | -1% | 89K |
| 01:00 UTC | -2% | 90K |
| 02:00 UTC | -3% | 88K |
| 03:00 UTC | -4% | 94K |
| 04:00 UTC | -5% | 76K |
| 05:00 UTC | -4% | 75K |
| 06:00 UTC | -5% | 86K |
| 07:00 UTC | -5% | 93K |
| 08:00 UTC | -4% | 108K |
| 09:00 UTC | -4% | 124K |
| 10:00 UTC | -3% | 129K |
| 11:00 UTC | -3% | 141K |
| 12:00 UTC | -3% | 154K |
| 13:00 UTC | -3% | 167K |
| 14:00 UTC | -4% | 173K |
| 15:00 UTC | -2% | 176K |
| 16:00 UTC | -3% | 171K |
| 17:00 UTC | -3% | 159K |
| 18:00 UTC | -2% | 149K |
| 19:00 UTC | -2% | 141K |
| 20:00 UTC | -1% | 131K |
| 21:00 UTC | 0% | 116K |
| 22:00 UTC | -2% | 100K |
| 23:00 UTC | -1% | 90K |
Show engagement by day of week as a table
| Day | Vs author median | Posts |
|---|---|---|
| Sunday | +5% | 393K |
| Monday | +1% | 483K |
| Tuesday | -2% | 520K |
| Wednesday | -3% | 472K |
| Thursday | -2% | 430K |
| Friday | -3% | 447K |
| Saturday | +2% | 393K |
Formats this account uses
Its own posting mix on the left, and what each of those formats does across every account we track on the right. Only formats where the effect clears our publish test appear here, so an empty row is a format we could not measure rather than one that does nothing.
| Format | This account | Catalog effect | 95% interval | Accounts behind it |
|---|---|---|---|---|
| Image or video | 91% of posts | +111% | +108% to +115% | 34K |
| Outbound link | 45% of posts | -41% | -42% to -40% | 32K |
| Typical length | - | no effect | -2% to -1% | 42K |
- 91% of this account's sampled posts carry an image or video. Across the catalog, posts with an image or video run 111% above the same accounts' other posts.
- 45% of its posts carry a link off X. Across the catalog, posts with an outbound link run 41% below the same accounts' other posts, so a large share of this account's output sits in the weakest bucket we measure.
- Its average post runs 261 characters, which falls in the 180 - 280 characters band. Across the catalog, posts of 180 to 280 characters match the same accounts' other posts almost exactly.
These are catalog-wide differences applied to this account's own posting mix, not a measurement of how each format performs for this account specifically. We keep one median per account, not one per format per account, so the second thing is not something this data can tell you.
Best tweets
- Jun 5, 20261.6x their median
Early #OCU410ST results show: ✓ 54% reduction in atrophic lesion growth ✓ 100% of treated eyes stabilized or improved ✓ +6 letter gain in visual acuity Hear from an OCU410ST clinical trial participant: https://t.co/znh5I8UL9R $OCGN https://t.co/yAHPuOLWoh
- May 26, 20261.6x their median
100,000+ people with #Stargardtdisease have no FDA approved treatment. #OCU410ST aims to slow or stop disease progression, with early promising data. Follow Ocugen and be part of something groundbreaking. #Biotech #Genetherapy $OCGN https://t.co/dCoeI8UbJA
- Sep 1, 20261.6x their median
Today, CEO @drsmusunuri announced a major advancement for #OCU410 and #geographicatrophy: the first patient dosed in our global Phase 3 trial. We are one step closer to a potential one-time treatment for life and our target of 3 BLAs by 2028. 🔗https://t.co/z2IBcOwzyI $OCGN https://t.co/Im7QiQeyUT
- Apr 15, 20261.5x their median
Phase 2 Update: A 31% reduction in GA lesion growth was observed with #OCU410 (medium dose) and a 27% EZ preservation in treated v. control supporting medium dose as optimal in Phase 3. #GeographicAtrophy #PatientImpact Latest corp. presentation: https://t.co/hIYAlBqgZQ https://t.co/OnXeHv4VAq
- Sep 9, 20261.5x their median
$OCGN https://t.co/JEVUvU9don
- Jun 24, 2026
Connie Collingsworth, Member of our Business Advisory Board and former COO of the @gatesfoundation, met with CEO @drsmusunuri this week to discuss global access partnerships as we work to advance transformative modifier gene therapies for patients around the world. #GlobalHealth https://t.co/zHhXgCLh4K
- Jul 29, 2026
Big milestone for #OCU410! The @FDA has granted RMAT designation to our investigational one-time gene therapy for #geographicatrophy, secondary to #dAMD, recognizing its potential to address a significant unmet need. #GeneTherapy Read more: https://t.co/Cs3118r4wJ https://t.co/sTxd9Dp2zw
- Aug 27, 2026
New #research from Ocugen’s scientific team in @FrontNeurosci explores RORα as a potential multi-pathway target in #Alzheimersdisease, including its role in neuroinflammation, oxidative stress, mitochondrial health, and circadian regulation. $OCGN Read: https://t.co/T1dx0LESOj
- Jun 9, 2026
What makes #OCU400 different? OCU400 is designed to address multiple RP mutations through a potential one-time therapy. Follow us for updates as we advance OCU400 toward a planned BLA submission this year. #RetinitisPigmentosa #GeneTherapy $OCGN https://t.co/ELs4GmT30G
- May 15, 2026
Momentum continues at Ocugen. With $130 million in financing secured, we are well-positioned to advance our three late-stage programs as we work toward filing three BLAs by 2028. Learn more: https://t.co/7nSj5EJkPZ #GeneTherapy #Biotech #FinancialUpdate $OCGN https://t.co/kvm53UaMg6
Ranked by total interactions across everything we have tracked for this account, which is a longer history than the 30-day window the rates above use. The multiple compares each post to this account's own median.
Recurring topics
The most frequent hashtags in the sampled posts. They describe what this account writes about; they are not a performance signal, and the catalog-wide breakdown on the hub shows how little hashtag count moves.
Buy or sell Twitter (X) accounts - escrow-protected
PlayerSells is an escrow marketplace for Twitter (X) accounts. Every deal is protected, with no middleman risk.
Reading these numbers
A typical post picks up 117 interactions against 65K followers, an engagement rate of 0.182%. Measured over 11 original posts, its engagement rate beats 58% of 21,185 tracked accounts of a similar size, which puts it in the middle of its size range rather than at either end. Posts are seen about 5.5K times each, and 2.14% of those impressions turn into an interaction. That is about 8.49% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 0.4 posts a day over the last 30 days, though only 40% of days saw any activity at all. Most posts go out around 13:00 UTC, and Tuesday is the busiest day of the week. Of the 11 posts sampled, 91% carry an image or video and 45% link out. The account's strongest tracked post pulled 189 interactions, about 1.6x its own typical post. Recurring topics include #ocu410, #biotech, #genetherapy.
- What is Ocugen's engagement rate on X?
- Ocugen (@Ocugen) has an engagement rate of 0.182%, based on the median interactions across 11 original posts from the last 30 days against 64,549 followers. Replies, reposts and quote-posts of other people are excluded from that sample.
- Is that a good engagement rate?
- At 0.182%, Ocugen sits above the 50th percentile of the 213,098 accounts in this comparison. Those comparison accounts are all large ones, because our scanning cadence is weighted towards big accounts, so this is a ranking among peers of similar scale rather than a ranking across X.
- Does @Ocugen have real engagement?
- Its engagement rate beats 58% of the tracked X accounts closest to it in follower count (21,185 accounts), which puts it in the middle of its size range group. Ranking inside a size band matters because engagement rate falls as accounts grow, so a raw rate would mostly re-measure the follower count. It is a starting point for a look at follower quality, not a verdict on it.
- When does @Ocugen post?
- Most posts go out around 13:00 UTC, and Tuesday is its busiest day, at roughly 0.4 posts per day across the measured window.